Superdrug announces it is the first UK high-street pharmacy to launch oral weight-loss tablets of Wegovy, rather than the injectable form. Multiple reports say the pharmacy is taking requests from people in Britain who want access to the treatment in tablet form. The medication is described as an oral version of Wegovy, which is widely known for being administered by injection. One outlet reports the tablets are set to go on sale at a price of £79, indicating an advertised cost for the product at the retailer. The announcements focus on availability through a high-street pharmacy and on a switch from injections to tablets, aiming to make the treatment easier to obtain for eligible customers. The coverage emphasizes Superdrug’s role in beginning the tablet launch and the process of taking requests, rather than detailing clinical information, eligibility criteria, or broader national rollout timelines.